Akero Therapeutics, 89bio, Boston Pharmaceuticals and more are working to bring novel treatment options for metabolic dysfunction-associated steatohepatitis to a market that could reach $16 billion by ...

Equities research analysts at Wedbush issued their FY2029 earnings per share (EPS) estimates for shares of Tyra Biosciences in a research report issued on Friday, March 28th. Wedbush analyst R.

Sei Investments Co. trimmed its holdings in shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Free Report) by 15.4% in ...

Colossal, a genetics startup, has birthed three pups that contain ancient DNA retrieved from the remains of the animal’s ...

A mysterious gene that makes Bengal cats’ fur shine like diamonds has left scientists quite intrigued. To begin with, it’s ...

Bengal cats are renowned for their striking, leopard-like coats and captivating presence. Among their many unique features, ...

In recent years, stem cells and epidermal growth factors have become key ingredients in skincare formulations. Some brands ...

A study in mice reveals key interactions between proteins involved in fibroblast growth factor signaling and how they contribute to distinct stages of eye lens development.

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) has become the most prevalent type of heart failure, but ...

In fact, it looks to have a long runway for growth as it expands across the United States. With a discounted price and a market cap below $1 billion, Portillo's is a great growth stock to buy ...

Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List ... Based on their value, growth, and momentum characteristics, each stock is assigned ...